Daily Aspirin May Curb COPD Exacerbations Daily Aspirin May Curb COPD Exacerbations
Daily aspirin use appears to reduce the risk of exacerbations and have other beneficial effects in patients with chronic obstructive pulmonary disease (COPD), according to an observational study.Reuters Health Information
Early accurate diagnosis and sustainable availability of affordable medicines and diagnostic tests is fundamental in optimal management of asthma and chronic obstructive pulmonary disease (COPD). We systematic...
(MedPage Today) -- Higher risk seen for supply-demand mismatch as with sepsis, though mechanisms of association unclear
ConclusionWhile most PCPs and respiratory/allergy specialists can reach a working diagnosis of ACO, there remains uncertainty around which diagnostic features are most important and what constitutes optimal management. It is imperative that clinical studies including patients with ACO are initiated, allowing the generation of evidence ‐based management strategies.This article is protected by copyright. All rights reserved.
The World Health Organization estimates that at least 300 million people suffer from asthma worldwide.1 Over 17.7 million adults suffer from asthma compared to the 6.3 million children who are also afflicted with asthma in the United States (U.S.).2 Older adults ages 65 and over with asthma are the fastest growing age-group in the U.S.3 Studies in the United States show that asthma and other reactive airway diseases are under-diagnosed among the elderly, that asthma-related morbidity and mortality among the elderly is increasing4 and that nationally the number of older adults dying from asthma is 14 times higher compared t...
Millions of Americans suffer from respiratory diseases, including Asthma and chronic obstructive pulmonary disease (COPD). Together, these two diseases affect the day-to-day lives of over 40 million patients in the U.S. Furthermore, respiratory allergies affect 10 percent of children under the age of 18. Not only do these diseases impact day-to-day functioning, but they can also be life-threatening.
Conclusion: GRNX effectively treated asthma and COPD patients with acute bacterial infection without severe adverse events. Further research with a larger study population is needed.Int Arch Allergy Immunol
This study investigated the expression of IL-17 by CD4+ T cells, ILC2 and ILC3 in COPD subjects.
Airway mucus overproduction is a common characteristic in chronic airway diseases such as chronic rhinosinusitis (CRS) and chronic obstructive pulmonary disease (COPD). Mucin 1 (MUC1), a membrane-associated mucin, interacts with epidermal growth factor receptor (EGFR) to stimulate epithelial mesenchymal transition (EMT). In chronic airway disease, EGFR activation results in overproduction of Mucin 5AC (MUC5AC) and goblet cell metaplasia (GCM). We investigated the role of MUC1 in mucus overproduction in chronic airway disease.
Chronically inflamed airways in asthma and chronic obstructive pulmonary disease (COPD) are susceptible to heightened neutrophilic inflammation but the underlying mechanisms are unclear. We previously showed that SP-D deficiency is associated with increased and prolonged neutrophilic inflammation of the airways in mice. Extracellular release of double stranded DNA by neutrophils contributes to the inflammatory injury. We hypothesized that SP-D interferes with this process.
The effects of opioid use on respiratory conditions are mixed – while licit opiates help with cough and the dyspnea of heart disease and chronic obstructive pulmonary disease, illicit opiates may exacerbate asthma. We hypothesized that there would be an increased prevalence of asthma in patients with chronic opioid dependence.